Literature DB >> 7719912

Immunoglobulin gene sequence analysis to further assess B-cell origin of multiple myeloma.

D D Biggs1, P Kraj, J Goldman, L Jefferies, C Carchidi, K Anderson, L E Silberstein.   

Abstract

To further characterize the B-cell origin of multiple myeloma, our laboratory performed immunoglobulin gene sequence analyses of four cases of myeloma (three immunoglobulin A and one immunoglobulin G). Three tumors expressed VH3 genes and one expressed a VH1 gene, while the light chains included two V lambda and one V kappa III; one light chain was not isolated. The closest homology to published germ line genes ranged from 91 to 97%. In two cases, the expressed VH genes were compared with the putative germ line precursor VH genes isolated from autologous granulocyte DNA and appeared to have mutated randomly from the germ line gene. By sequencing multiple clonal isolates from each tumor sample, we found no evidence for ongoing mutation in three cases; in one case, however, clonotypic heterogeneity was evident. The analysis of DH- and JH-region genes revealed (i) limited or absent N nucleotide insertions (two of four cases), (ii) the presence of a DH-JH junction resulting from sequence overlap between the DH and JH genes (one of four cases), (iii) the absence of somatic mutations (two of four cases), and (iv) restricted JH gene usage of a JH6 polymorphism (three of four cases). These analyses of DH and JH genes suggest that multiple myeloma, similar to what has been proposed for chronic lymphocytic leukemia, may derive from B cells which have rearranged during fetal development rather than during adult life.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719912      PMCID: PMC170099          DOI: 10.1128/cdli.2.1.44-52.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  59 in total

1.  Immunoglobulin heavy and light chain gene sequences of a human CD5 positive immunocytoma and sequences of four novel VHIII germline genes.

Authors:  R Küppers; U Fischer; K Rajewsky; A Gause
Journal:  Immunol Lett       Date:  1992-09       Impact factor: 3.685

2.  Emerging human B cell repertoire. Influence of developmental stage and interindividual variation.

Authors:  J L Hillson; I R Oppliger; E H Sasso; E C Milner; M H Wener
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

3.  Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

Authors:  J V Ravetch; U Siebenlist; S Korsmeyer; T Waldmann; P Leder
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  Mechanisms that generate human immunoglobulin diversity operate from the 8th week of gestation in fetal liver.

Authors:  A M Cuisinier; L Gauthier; L Boubli; M Fougereau; C Tonnelle
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

5.  Cloning and sequencing of human immunoglobulin V lambda gene segments.

Authors:  S C Williams; G Winter
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

6.  Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases.

Authors:  T Isobe; E F Osserman
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

7.  Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia.

Authors:  T J Kipps; E Tomhave; L F Pratt; S Duffy; P P Chen; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma.

Authors:  D L Saltman; J A Ross; R E Banks; F M Ross; A M Ford; M J Mackie
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

9.  Human cord blood antibody repertoire. Mixed population of VH gene segments and CDR3 distribution in the expressed C alpha and C gamma repertoires.

Authors:  F Mortari; J Y Wang; H W Schroeder
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

10.  Ras oncogene mutation in multiple myeloma.

Authors:  A Neri; J P Murphy; L Cro; D Ferrero; C Tarella; L Baldini; R Dalla-Favera
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  3 in total

Review 1.  The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.

Authors:  Nikolaos Giannakoulas; Ioannis Ntanasis-Stathopoulos; Evangelos Terpos
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

2.  Comprehensive assessment of potential multiple myeloma immunoglobulin heavy chain V-D-J intraclonal variation using massively parallel pyrosequencing.

Authors:  Renee C Tschumper; Yan W Asmann; Asif Hossain; Paul M Huddleston; Xiaosheng Wu; Angela Dispenzieri; Bruce W Eckloff; Diane F Jelinek
Journal:  Oncotarget       Date:  2012-04

3.  The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression.

Authors:  C Arpin; O de Bouteiller; D Razanajaona; I Fugier-Vivier; F Brière; J Banchereau; S Lebecque; Y J Liu
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.